UCSC Human Gene Sorter
 
genome assembly search
sort by display output 
#
Name
VisiGene
BLASTP
E-Value
Genome Position
Description
1NAPSBn/a
n/a
n/a
n/a
n/achr19 50,339,319napsin B aspartic peptidase, pseudogene (from HGNC NAPSB)
2MAP4K1n/a
n/a
n/a
n/a
n/achr19 38,602,797mitogen-activated protein kinase kinase kinase kinase 1, transcript variant 1 (from RefSeq NM_001042600.3)
3SLAMF6n/a
n/a
n/a
n/a
n/achr1 160,504,145SLAM family member 6, transcript variant 1 (from RefSeq NM_001184714.2)
4HLA-DOBn/a
n/a
n/a
n/a
n/achr6 32,814,882major histocompatibility complex, class II, DO beta (from RefSeq NM_002120.4)
5MIR142n/a
n/a
n/a
n/a
n/achr17 58,331,275microRNA 142 (from RefSeq NR_029683.1)
6LY86n/a
n/a
n/a
n/a
n/achr6 6,621,851lymphocyte antigen 86 (from RefSeq NM_004271.4)
7IGHJ1n/a
    
    
     
n/achr14 105,865,432J region of the variable domain of immunoglobulin heavy  chains that participates in the antigen recognition (PubMed:24600447).  Immunoglobulins, also known as antibodies, are membrane-bound or  secreted glycoproteins produced by B lymphocytes. In the recognition  phase of humoral immunity, the membrane-bound immunoglobulins serve as  receptors which, upon binding of a specific antigen, trigger the clonal  expansion and differentiation of B lymphocytes into immunoglobulins-  secreting plasma cells. Secreted immunoglobulins mediate the effector  phase of humoral immunity, which results in the elimination of bound  antigens (PubMed:22158414, PubMed:20176268). The antigen binding site  is formed by the variable domain of one heavy chain, together with that  of its associated light chain. Thus, each immunoglobulin has two  antigen binding sites with remarkable affinity for a particular  antigen. The variable domains are assembled by a process called V-(D)-J  rearrangement and can then be subjected to somatic hypermutations  which, after exposure to antigen and selection, allow affinity  maturation for a particular antigen (PubMed:20176268, PubMed:17576170). (from UniProt A0A0C4DH62)
8BLKn/a
n/a
n/a
n/a
n/achr8 11,529,493BLK proto-oncogene, Src family tyrosine kinase, transcript variant 1 (from RefSeq NM_001715.3)
9IRF8n/a
n/a
n/a
n/a
n/achr16 85,910,884interferon regulatory factor 8, transcript variant 2 (from RefSeq NM_002163.4)
10IL2RBn/a
n/a
n/a
n/a
n/achr22 37,137,879interleukin 2 receptor subunit beta, transcript variant 1 (from RefSeq NM_000878.5)
11LCKn/a
n/a
n/a
n/a
n/achr1 32,268,715LCK proto-oncogene, Src family tyrosine kinase, transcript variant 2 (from RefSeq NM_005356.5)
12SIT1n/a
n/a
n/a
n/a
n/achr9 35,650,113signaling threshold regulating transmembrane adaptor 1 (from RefSeq NM_014450.3)
13ITGB7n/a
n/a
n/a
n/a
n/achr12 53,199,287integrin subunit beta 7, transcript variant 20 (from RefSeq NR_182253.1)
14TRAF3IP3n/a
n/a
n/a
n/a
n/achr1 209,769,181TRAF3 interacting protein 3, transcript variant 1 (from RefSeq NM_025228.4)
15IKZF3n/a
n/a
n/a
n/a
n/achr17 39,811,015IKAROS family zinc finger 3, transcript variant 1 (from RefSeq NM_012481.5)
16DENND1Cn/a
n/a
n/a
n/a
n/achr19 6,474,497DENN domain containing 1C, transcript variant 1 (from RefSeq NM_024898.4)
17CALHM6n/a
n/a
n/a
n/a
n/achr6 116,462,573calcium homeostasis modulator family member 6, transcript variant 1 (from RefSeq NM_001010919.3)
18ENSG00000285446n/a
n/a
n/a
n/a
n/achr6 116,431,545Membrane ; Multi-  pass membrane protein (from UniProt A0A2R8Y6J1)
19PARP15n/a
n/a
n/a
n/a
n/achr3 122,608,348poly(ADP-ribose) polymerase family member 15, transcript variant 1 (from RefSeq NM_001113523.3)
20RASAL3n/a
n/a
n/a
n/a
n/achr19 15,458,084RAS protein activator like 3, transcript variant 10 (from RefSeq NR_174478.1)
21SCIMPn/a
n/a
n/a
n/a
n/achr17 5,221,890SLP adaptor and CSK interacting membrane protein, transcript variant 1 (from RefSeq NM_207103.3)
22SIGLEC10n/a
n/a
n/a
n/a
n/achr19 51,413,831sialic acid binding Ig like lectin 10, transcript variant 1 (from RefSeq NM_033130.5)
23SASH3n/a
    
    
     
n/achrX 129,787,575SAM and SH3 domain containing 3 (from RefSeq NM_018990.4)
24ENSG00000240143n/a
    
    
     
n/achrX 129,795,978ENSG00000240143 (from geneSymbol)
25VPREB3n/a
    
    
     
n/achr22 23,753,584V-set pre-B cell surrogate light chain 3 (from RefSeq NM_013378.3)
26CORO1A-AS1n/a
    
    
     
n/achr16 30,184,014CORO1A antisense RNA 1, transcript variant 2 (from RefSeq NR_186358.1)
27HLA-DQA2n/a
    
    
     
n/achr6 32,744,294major histocompatibility complex, class II, DQ alpha 2 (from RefSeq NM_020056.5)
28CCR7n/a
    
    
     
n/achr17 40,559,620C-C motif chemokine receptor 7, transcript variant 1 (from RefSeq NM_001838.4)
29TNFRSF17n/a
n/a
n/a
n/a
n/achr16 11,966,639TNF receptor superfamily member 17 (from RefSeq NM_001192.3)
30CCL3-AS1n/a
n/a
n/a
n/a
n/achr17 36,081,361CCL3-AS1 (from geneSymbol)
31ITGALn/a
n/a
n/a
n/a
n/achr16 30,497,963integrin subunit alpha L, transcript variant 1 (from RefSeq NM_002209.3)
32MCOLN2n/a
n/a
n/a
n/a
n/achr1 84,961,348mucolipin TRP cation channel 2, transcript variant 1 (from RefSeq NM_153259.4)
33PIK3AP1n/a
n/a
n/a
n/a
n/achr10 96,656,914phosphoinositide-3-kinase adaptor protein 1 (from RefSeq NM_152309.3)
34SPNn/a
n/a
n/a
n/a
n/achr16 29,667,061sialophorin, transcript variant 2 (from RefSeq NM_003123.6)
35HLA-DOAn/a
n/a
n/a
n/a
n/achr6 33,006,886major histocompatibility complex, class II, DO alpha (from RefSeq NM_002119.4)
36TLR10n/a
n/a
n/a
n/a
n/achr4 38,777,614toll like receptor 10, transcript variant 1 (from RefSeq NM_030956.4)
37SIGLEC10-AS2n/a
    
    
     
n/achr19 51,414,631SIGLEC10-AS2 (from geneSymbol)
38TNFn/a
    
    
     
n/achr6 31,576,950tumor necrosis factor (from RefSeq NM_000594.4)
39IKZF1n/a
n/a
n/a
n/a
n/achr7 50,354,908IKAROS family zinc finger 1, transcript variant 1 (from RefSeq NM_006060.6)
40LY75n/a
n/a
n/a
n/a
n/achr2 159,854,055lymphocyte antigen 75 (from RefSeq NM_002349.4)
41CD86n/a
n/a
n/a
n/a
n/achr3 122,088,249CD86 molecule, transcript variant 1 (from RefSeq NM_175862.5)
42CD69n/a
n/a
n/a
n/a
n/achr12 9,756,693CD69 molecule (from RefSeq NM_001781.2)
43SP140n/a
n/a
n/a
n/a
n/achr2 230,269,475SP140 nuclear body protein, transcript variant 1 (from RefSeq NM_007237.5)
44CCL4n/a
n/a
n/a
n/a
n/achr17 36,104,720C-C motif chemokine ligand 4 (from RefSeq NM_002984.4)
45IRF5n/a
n/a
n/a
n/a
n/achr7 128,943,982interferon regulatory factor 5, transcript variant 10 (from RefSeq NM_001364314.2)
46ITGA4n/a
n/a
n/a
n/a
n/achr2 181,498,163integrin subunit alpha 4, transcript variant 1 (from RefSeq NM_000885.6)
47PARVGn/a
n/a
n/a
n/a
n/achr22 44,194,697parvin gamma, transcript variant 1 (from RefSeq NM_022141.7)
48TBC1D27Pn/a
n/a
n/a
n/a
n/achr17 16,928,250TBC1 domain family member 27, pseudogene (from HGNC TBC1D27P)
49ENSG00000290698n/a
n/a
n/a
n/a
n/achr17 16,928,877TBC1 domain family member 27, pseudogene (from RefSeq NR_147084.1)
50IL21Rn/a
n/a
n/a
n/a
n/achr16 27,427,108interleukin 21 receptor, transcript variant 2 (from RefSeq NM_181078.3)